Adding Pioglitazone to Insulin Containing Regimens in Type 2 Diabetes: Systematic Review and Meta-Analysis

BACKGROUND: Type 2 diabetes is treated in a stepwise manner, progressing from diet and physical activity to oral antidiabetic agents and insulin. The oral agent pioglitazone is licensed for use with insulin when metformin is contraindicated or not tolerated. This systematic review and meta-analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Clar, Christine, Royle, Pamela, Waugh, Norman
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701605/
https://www.ncbi.nlm.nih.gov/pubmed/19568428
http://dx.doi.org/10.1371/journal.pone.0006112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701605/
https://www.ncbi.nlm.nih.gov/pubmed/19568428
http://dx.doi.org/10.1371/journal.pone.0006112

Ejemplares similares